The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / How to Improve Oral & Eye Health in Sjögren’s Patients

How to Improve Oral & Eye Health in Sjögren’s Patients

March 15, 2021 • By Vanessa Caceres

  • Tweet
  • Email
Print-Friendly Version / Save PDF
FunKey Factory / shutterstock.com

FunKey Factory / shutterstock.com

ACR CONVERGENCE 2020—Sjögren’s syndrome requires care from several specialists, and presenters at the Sjögren’s Syndrome: Dental and Ocular Perspectives session shared diagnostic and treatment pearls from their respective specialties. 

You Might Also Like
  • Research Underscores Need to Assess Oral Health in Patients with Systemic Sclerosis
  • New Options for Patients with Concurrent Dry Eye & Rheumatic Disease
  • Autologous Serum Tears Receives High Patient Satisfaction Scores for Dry Eye Disease
Explore This Issue
March 2021
Also By This Author
  • PCSK9 Inhibitors May Lower Cholesterol in Patients with Statin-Associated Immune-Mediated Necrotizing Myopathy

Rebecca Manno, MD, MHS, of the Comprehensive Arthritis and Rheumatology Center of the U.S. Virgin Islands moderated the session. 

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Oral Health

Dry mouth is famously associated with Sjögren’s syndrome, but there are other oral-related problems, said Athena S. Papas, DMD, PhD, distinguished professor of diagnostic sciences and Erling Johansen Professor of Dental Research, Tufts University School of Dental Medicine, Boston. A survey of 3,000 people with Sjögren’s syndrome from the Sjögren’s Foundation found 92% had dry mouth, 66% had ulcers, 61% had trouble speaking, 59% had tooth decay and 45% had gastro­esophageal reflux disease, Dr. Papas shared. 

The loss of saliva has severe consequences for oral care, Dr. Papas said. One challenge in preventing problems is that the disease is often diagnosed late. 

Dr. Papas

Dr. Papas

Dentists offer several treatments to help patients with Sjögren’s syndrome prevent or reduce tooth decay, including a fluoride varnish, performed every three months, and a 1.1% sodium fluoride toothpaste patients can use daily. Re-mineralizing solutions, such as a supersaturated calcium phosphate rinse (NeutraSal) and Caphosol, also help prevent tooth decay, Dr. Papas said. 

Sialogogues, such as pilocarpine (Salagen) and cevimeline (Evoxac), and xylitol-containing gum are additional options to help increase saliva.

You may also want to consider a secretagogue for Sjögren’s patients. When prescribing a secretagogue to help with dry mouth, Dr. Papas recommended starting with a low dose and going slow, such as one tablet a week, then two tablets a week, and working up from there. If one secretagogue does not work, try another. Patients may find secretagogues help with other dryness issues, such as vaginal dryness, as well. 

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Omega-3 fatty acid supplements have also been shown to help dry mouth symptoms and overall periodontal health in patients with Sjögren’s syndrome, Dr. Papas said. 

For patients who have trouble speaking or swallowing, options such as vitamin E, mineral oil or olive oil can potentially help. 

Eye Health

Dr. Akpek

Dr. Akpek

Although many ophthalmologists treat dry eye, they may not always know in detail the connection between dry eye and Sjögren’s syndrome, said Esen K. Akpek, MD, the Bendann Professor of Ophthalmology and Rheumatology at the Wilmer Eye Institute at Johns Hopkins University School of Medicine, Baltimore, director of the Ocular Surface Disease and Dry Eye Clinic at Wilmer, and associate director of the Jerome L. Greene Sjögren’s Center at Johns Hopkins Bayview Medical Center. 

A 2016 survey from the Sjögren’s Syndrome Foundation revealed that 98% of patients complained of dry eye, Dr. Akpek reported. Among the patients in the survey, only 5% were referred to a rheumatologist for a Sjögren’s syndrome evaluation by an eye care provider. This is because Sjögren’s syndrome is often under-recognized and underappreciated by ophthalmologists, Dr. Akpek said. 

One study showed that among patients with dry eye, 25.9% had an underlying disease, such as Sjögren’s syndrome, lupus or rheumatoid arthritis, Dr. Akpek said.1 Another study showed 11.6% of patients with dry eye had underlying Sjögren’s syndrome.2 Dry eye among those with Sjögren’s syndrome frequently affects quality of life and has an impact on everyday tasks, such as reading speed. 

Although dry eye in Sjögren’s syndrome is primarily due to a deficiency of aqueous humor, all tear film layers will be affected over time, Dr. Akpek explained. Diagnostic tools used by ophthalmologists for dry eye include tear break-up time and tear osmolarity. 

Physicians may traditionally think of dry eye as the primary eye problem for those with Sjögren’s, but extraglandular findings also are common, including vision-threatening findings, Dr. Akpek said. These can include iritis, anterior and posterior uveitis and peripheral corneal neovascularization. Dry eye may precede these other findings by a decade. “The eye seems to be a barometer of disease activity,” she said. 

Neither rheumatologists nor ophthalmologists should forget to consider Sjögren’s syndrome as a possibility in men, particularly if they have aqueous-deficient dry eye, Dr. Akpek said.3 Physicians may not think about this because the disease is more commonly associated with middle-aged women. 

Ophthalmologists who treat dry eye in Sjögren’s syndrome patients take a stepwise approach depending on its severity. They educate patients, suggest the modification of environmental factors and addition of lubricants. 

Both ophthalmologists and rheumatologists may suggest artificial tears. If there is a strong need for artificial tears, the patient should use preservative-free ones, Dr. Akpek said. If the patient needs tears more than eight times a day, they should look at other treatment options to avoid depleting natural tears. “More is not better with artificial tears,” she said. 

After these first steps, ophthalmologists may prescribe topical immunomodulators, such as lifitegrast and cyclosporine A. They may also recommend tear duct plugs, topical corticosteroids, secretagogues, scleral lenses and autologous serum tears, among other treatments, Dr. Akpek said.

Pages: 1 2 | Single Page

Filed Under: Conditions, Systemic Inflammatory Syndromes Tagged With: ACR Convergence 2020, Dry eye, oral health, Sjögren's syndromeIssue: March 2021

You Might Also Like:
  • Research Underscores Need to Assess Oral Health in Patients with Systemic Sclerosis
  • New Options for Patients with Concurrent Dry Eye & Rheumatic Disease
  • Autologous Serum Tears Receives High Patient Satisfaction Scores for Dry Eye Disease
  • Lacrimal & Tear Fluid Yield Clues to Dry Eye Disease

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)